Stigninger i serum- ALAT, der optrådte hos patienter med kompenseret leverfunktion behandlet med 10 mg adefovirdipivoxil, var ikke ledsaget af kliniske og laboratoriebaserede ændringer forbundet med leverdekompensation.
Elevations in serum ALT that occurred in patients with compensated liver function treated with 10 mg adefovir dipivoxil were not accompanied by clinical and laboratory changes associated with liver decompensation.